WGS · GeneDx Holdings Corp. · Documents

$52.37 +0.50 (+0.96%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$1.57B

29.97M

Volume · Nov 13 1.12M Avg daily vol (3M) 804.77K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024

Jul 30

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $70.51M ▲ 44.8% Net loss $29.17M Diluted EPS -$1.10

Jun 24

Current report 8-K Events of Jun 20

Shareholder vote results

Apr 29

Current report 8-K

Financial results

Apr 29

Proxy statement DEF 14A

Proxy statement

Apr 29

Earnings call

Q1 2024 earnings call

Apr 29

Current report 8-K

Entered into a material agreement

Apr 29

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $62.42M ▲ 44.7% Net loss $20.24M Diluted EPS -$0.78

Apr 29

Annual report to holders ARS

Annual report to holders

Apr 29

Proxy statement DEFA14A

Proxy statement

Feb 23

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $202.57M ▼ 13.7% Net loss $175.77M Diluted EPS -$7.23

Feb 20

Earnings call

Q4 2023 earnings call

Feb 20

Current report 8-K

Financial results

Jan 8

Current report 8-K

Financial results, Regulation FD disclosure

2023

Nov 3

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $53.3M ▼ 36.0% Net loss $42.29M Diluted EPS -$1.64

Oct 30

Earnings call

Q3 2023 earnings call

Oct 30

Current report 8-K Events of Oct 27

Entered into a material agreement, Ended a material agreement, Financial results, New debt or off-balance-sheet obligation, Unregistered sale of equity

Aug 8

Earnings call

Q2 2023 earnings call

Aug 8

Current report 8-K

Financial results

Aug 8

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $48.71M ▲ 34.7% Net loss $46.72M Diluted EPS -$1.84

Jul 24

Current report 8-K Events of Jul 21

Director or officer change, or executive pay

Jun 20

Current report 8-K Events of Jun 14

Shareholder vote results

Jun 6

Proxy statement DEFA14A

Proxy statement

May 22

Current report 8-K Events of May 18

Other events

May 9

Earnings call

Q1 2023 earnings call

May 9

Current report 8-K

Financial results

May 9

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $43.14M ▼ 20.0% Net loss $60.99M Diluted EPS -$3.04

May 8

Annual report to holders ARS

Annual report to holders

Apr 28

Proxy statement DEF 14A

Proxy statement

Apr 28

Current report 8-K Events of Apr 24

Change to shareholders' rights, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events

Apr 17

Current report 8-K Events of Apr 14

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results

Apr 14

Current report 8-K Events of Apr 12

Director or officer change, or executive pay

Mar 31

Proxy statement DEF 14A Meeting Apr 14, 2023

Proxy statement

Mar 21

Proxy statement PRE 14A Meeting Apr 14, 2023

Proxy statement

Mar 16

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $234.69M ▲ 10.6% Net loss $548.98M Diluted EPS -$1.63

Mar 14

Earnings call

Q4 2022 earnings call

Mar 14

Current report 8-K

Financial results

Feb 14

Current report 8-K

Director or officer change, or executive pay

Jan 30

Current report 8-K Events of Jan 26

Entered into a material agreement

Jan 12

Current report 8-K

Regulation FD disclosure

Jan 9

Current report 8-K

Financial results, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure

2022

Dec 30

Current report 8-K Events of Dec 28

Delisting notice or listing transfer, Other events

Nov 14

Earnings call

Q3 2022 earnings call

Nov 14

Current report 8-K Events of Nov 11

Financial results, Exit or restructuring costs

Nov 14

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $83.23M ▲ 92.8% Net loss $77.58M Diluted EPS -$0.20

Aug 26

Current report 8-K Events of Aug 25

Director or officer change, or executive pay, Regulation FD disclosure, Other events

Aug 26

Registration statement S-3

Registration statement

Aug 26

Registration statement S-3

Registration statement

Aug 15

Earnings call

Q2 2022 earnings call

Aug 15

Current report 8-K

Financial results, Regulation FD disclosure

Aug 15

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $36.17M ▼ 23.1% Net loss $85.74M Diluted EPS -$0.25

Showing 51–100 of 161 documents

Key facts CIK 1818331 CUSIP 81663L200 13F (30d) 171 filings 144 filers Visit website Investor relations